• G. H. Blijham


Das Analkarzinom kann im Plattenepithel distal des Analrandes (auch „Analrand“-Karzinom genannt) entstehen oder im Platten- und Zylinderepithel, das den Analkanal distal bzw. proximal der Linea dentata auskleidet. Die meisten Tumoren sind daher Plattenepithelkarzinome (ca. 65%) oder Übergangsepithel- (kloakogene) Karzinome (ca. 25%). Weitere Histologien beinhalten Adenokarzinome, kleinzellige Karzinome, Basalzellkarzinome und Melanome. Letztere zeigen eine schlechte Prognose mit einer 5-Jahres-Überlebensrate von ca. 10%.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shank B, Cohen AM, Kelsen D (1989) Cancer of the anal region. In: DeVita V, Hellman S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology. JB Lippincott, 4e edition, Philadelphia, pp 1006–1022Google Scholar
  2. 2.
    Peters RK, Mack TM (1983) Patterns and anal carcinoma by gender and marital status in Los Angeles Country. Br J Cancer 48: 629–636PubMedCrossRefGoogle Scholar
  3. 3.
    Daling JR, Weiss NS, Wislop G et al. (1987) Sexual practices, sexually transmitted diseases and the incidence of anal cancer. N Eng J Med 317: 973–977CrossRefGoogle Scholar
  4. 4.
    Dougherty B, Evans H (1985) Carcinoma of the anal canal: a study of 79 cases. Am J Clin Pathol 83: 159–164PubMedGoogle Scholar
  5. 5.
    Wanebo HJ, Woodruff JM, Farr GH et al. (1981) Anorectal melanoma. Cancer 47: 1891–1900PubMedCrossRefGoogle Scholar
  6. 6.
    Hermanek P, Sobin LH (eds) (1992) TNM classification of malignant tumours. Springer Verlag, New York 4th ed, 2nd revisionGoogle Scholar
  7. 7.
    Palillon J, Montcarbon JF (1987) Epidermoid carcinoma of the anal canal: a series of 275 cases. Dis Colon Rectum 30: 324–333CrossRefGoogle Scholar
  8. 8.
    Salmon RJ, Zafrani B, Habib A et al. (1986) Prognosis of cloacogenic and squamous cancer of the anal canal. Dis Colon Rectum 29: 336–430PubMedCrossRefGoogle Scholar
  9. 9.
    Goldman S, Auer G, Erhard K et al. (1987) Prognostic significance of clinical stage, histologic grade and nuclear DNA content in squamous cell carcinoma of the anus. Dis Colon Rectum 30: 444–448PubMedCrossRefGoogle Scholar
  10. 10.
    Boman BM, Moertel CG, O’Connel MJ et al. (1984) Carcinoma of the anal canal: a clinical and pathologic study of 188 cases. Cancer 54: 114–125PubMedCrossRefGoogle Scholar
  11. 11.
    Greenall MJ, Quan SHW, Stearns MW et al. (1985) Epidermoid cancer of the anal margin. Am J Surg 149: 95–101PubMedCrossRefGoogle Scholar
  12. 12.
    Al-Juif AS,Turnbul RB, Fazio VW (1979) Local treatment of squamous cell carcinoma of the anus. Surg Gynecol Obstet 148: 576–578Google Scholar
  13. 13.
    Greenall M, Magill G, Quan S et al. (1986) Recurrent epidermoid cancer of the anus Cancer 57: 1437–1441Google Scholar
  14. 14.
    Salmon RJ, Fenton J, Asselain B et al. (1984) Treatment of epidermoid anal canal cancer. Am J Surg 147: 43–48PubMedCrossRefGoogle Scholar
  15. 15.
    Eschwege F, Lasser P, Chavy A et al. (1985) Squamous cell carcinoma of the anal canal: treatment by external beam irradiation. Radiother Oncol 3: 145–150PubMedCrossRefGoogle Scholar
  16. 16.
    Salem P, Habboubi N, Naanasissie E et al. (1985) Effectiveness of cisplatin in the treatment of anal squamous cell carcinoma. Cancer Treat Rep 69: 891–893PubMedGoogle Scholar
  17. 17.
    Wilkin N, Petrell N, Herrera L et al. (1985) Phase II study of combination of bleomycin, vincristine and high-dose methotrexate ( BOM) with leucovorin rescue in advanced squamous cell carcinoma of the anal canal. Cancer Chemother Pharmacol 15: 300–302Google Scholar
  18. 18.
    Nigro ND (1987) Multidisciplinary management of cancer of the anus. World J Surg 11: 446–451PubMedCrossRefGoogle Scholar
  19. 19.
    Ajlouni M, Mahrt D, Milad MP (1984) Review of recent experience in the treatment of carcinoma of the anal canal. Am J Clin Oncol 7: 687–691PubMedCrossRefGoogle Scholar
  20. 20.
    John MJ, Flam M, Lovalvo L et al. (1987) Feasibility of non-surgical definitive management of anal canal carcinoma. Int J Radiat Oncol Biol Phys 13:299 — 303PubMedCrossRefGoogle Scholar
  21. 21.
    Tanum G, Tveit K, Karlson KO et al. (1991) Chemotherapy and radiation therapy for anal carcinoma. Cancer 67: 2462–2466PubMedCrossRefGoogle Scholar
  22. 22.
    Miller EJ, Quan SH, Thaler T (1991) Treatment of squamous cell carcinoma of the anal canal. Cancer 67: 2038–2041PubMedCrossRefGoogle Scholar
  23. 23.
    Zucali R, Doci R, Bombelli L (1990) Combined chemotherapy-radiotherapy of anal cancer. In J Radiat Oncol Biol Phys 19:1221–1223CrossRefGoogle Scholar
  24. 24.
    Cummings BJ, Keane TJ, O’Sullivan B et al. (1991) Epidermoid anal cancer. Treatment by radiation alone or by radiation and 5-Fluororuacil with and without mitomycin C. Int J Radiat Oncol Phys 21: 115–1125Google Scholar
  25. 25.
    Flam MS, John MJ, Peters T et al. (1993) Radiation and 5-FU versus radiation, 5-FU, MMC in the treatment of anal carcinoma. Preliminary results of a phase II randomized RTOG/ECOG Intergroup trial. Proc ASCO 12: 192Google Scholar
  26. 26.
    Diaz E, Young K, de la Rosa E (1993) Cisplatin and 5-FU plus simultaneous radiotherapy for the treatment of epidermoid carcinoma of the anal region. Proc ASCO 12: 190Google Scholar
  27. 27.
    Roca E, Penella E, Milano C et al. (1993) Efficacy of cisplatin with 5-FU plus alternating radiotherapy as first line treatment in anal canal cancer. Long term results. Proc ASCO 12: 206Google Scholar
  28. 28.
    Rosenblatt E, Chandha M, Malamud S et al. (1993) Toxicity of combined modality treatment for squamous cell carcinoma of the anus in patients at risk for human immune deficiency virus ( HIV ). Proc ASCO 12: 214Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • G. H. Blijham

There are no affiliations available

Personalised recommendations